This volume develops digital twins and therapeutic interventions in pharmacology, highlighting advanced drug design approaches.
This second applied-mathematics volume (Applied Mathematics Volume II) extends the GaoZheng G-Framework and GaoZheng G-Algebra from law-space field theories, GRL, and quantum computing (developed in the first applications volume) to life systems, pharmacology, and generative precision medicine. Building on the integrated construction of law-space geometry and PFB-GNLA in the pure mathematics volume, and on the law-space path-integral machinery introduced in Applied Mathematics Volume I, we treat life law-objects as primary mathematical entities. Structurally, the volume is organised around two complementary modelling tasks. The first develops law-space formulations of "simulated human" digital twins as large, time-dependent dynamical systems that approximate continuously evolving biological reality. The second treats inverse drug design as a discrete, algebraic programme based on GRL path integrals and discrete GRL-SAC decision mechanisms, in which therapeutic interventions are represented as composable operator instructions within the LBOPB framework. At the law level, the Life Bio-Operator Principal Bundle (LBOPB) packages heterogeneous life-science data pathology, physiology, toxicology, pharmacokinetics, pharmacodynamics, pharmacogenomics, and immunology into a unified total-operator principal bundle. Seven operator monoids (PEM, PRM, TEM, PKTM, PGOM, PDEM, IEM) model the dynamics of disease evolution, physiological regulation, toxic effects, drug transport, pharmacogenomic programming, pharmacodynamic response, and immune effects. Law-connections on these monoids define consistent cross-view "translations" between reference frames, while discrete GRL path integrals over operator sequences implement computable approximations to law-space dynamics. At the implementation level, the volume organises a structural chain from generative chemistry and classical molecular dynamics, through LBOPB-based operator monoids and powerset constructions, to GRL-SAC decision engines such as rlsac_id_unixtime. The resulting framework supports "simulated human" digital twins, virtual clinical trials, and compiler-like knowledge-compression schemes for life sciences. The overarching goal is to turn the G-Framework view of science from descriptive mapping to generative law-level construction- into a concrete, testable, and extensible paradigm for generative precision medicine. New in v1.1 (Redefined the source of GRL path integrals.) Version 1.1 removes the reference to Sutton and Barto in Chapter 6.1 to define GRL path integrals exclusively through Applied Mathematics Volume I of the series, resulting in a reduced and re-indexed bibliography that reinforces internal theoretical consistency
No takes yet. Share an insight, caveat, or question.
Gao Zheng (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: